Meadow Creek Investment Management’s bluebird bio BLUE Stock Holding History

Meadow Creek Investment Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-372	Closed	-$703K	–	1322
2018 Q3	$703K	Sell	372 -131	-26%	-$271K	0.01%	591
2018 Q2	$1.02M	Sell	503 -74	-13%	-$169K	0.02%	429
2018 Q1	$1.28M	Sell	577 -170	-23%	-$432K	0.03%	365
2017 Q4	$1.72M	Sell	747 -119	-14%	-$242K	0.04%	337
2017 Q3	$1.54M	Sell	866 -46	-5%	-$64.3K	0.04%	327
2017 Q2	$1.24M	Buy	912 +51	+6%	+$61.5K	0.03%	373
2017 Q1	$1.01M	Hold	861	–	–	0.02%	390
2016 Q4	$688K	Buy	+861	New	+$684K	0.02%	440

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Meadow Creek Investment Management's BLUE Position: Q4 2018 in Review

Meadow Creek Investment Management sold out of bluebird bio (BLUE) in Q4 2018, closing a stake of 372 shares — an estimated $703K sold.

Meadow Creek Investment Management first reported a position in BLUE in Q4 2016 and held it in 8 quarters. The position peaked at $1.72M in Q4 2017. 251 funds tracked by Wall St. Rank hold BLUE as of Q4 2018.

Meadow Creek Investment Management reported no remaining bluebird bio position as of Q4 2018 after selling out during the quarter.
Meadow Creek Investment Management sold 372 bluebird bio shares in Q4 2018, an estimated $703K.
Meadow Creek Investment Management first reported a position in bluebird bio in Q4 2016 and held it in 8 quarters.
Meadow Creek Investment Management's bluebird bio position peaked at $1.72M in Q4 2017.
251 funds tracked by Wall St. Rank held bluebird bio as of Q4 2018.

Based on Meadow Creek Investment Management's 13F filing for Q4 2018, filed 13 Feb 2019.